Immunohematology Market Report by Product, Technology (Biochips, Gel Cards, Microplates, Polymerase Chain Reaction, Erythrocyte-Magnetized Technology, and Others), Application, End-User, and Region 2024-2032
세계의 면역혈액학 시장 규모는 2023년 19억 달러에 달했습니다. 향후 IMARC Group은 시장이 2032년까지 28억 달러에 이를 전망이며 2024년과 2032년 사이에 4.2%의 복합 연간 성장률(CAGR)을 나타낼 것으로 예측했습니다.
면역혈액학은 면역계와 관련된 혈액과 조혈 조직을 연구하는 의학의 한 분야입니다. 혈액 중 항원의 존재와 용혈과 적혈구 응집을 일으키는 항체의 반응을 연구합니다. 다양한 면역혈액학적 검사는 안전한 수혈을 보장하고 원치 않는 면역반응, 이식반응, 임신반응을 예방하고 HIV, 간염 등 혈액 관련 질환과 질병을 진단하기 위해 실시 . 이러한 검사에는 마이크로플레이트, 바이오칩, 겔 카드, 중합효소 연쇄반응, 적혈구자화기술(EMT) 등의 기술에 근거한 시약, 자동,반자동 분석장치 등 다양한 화학약품과 장치가 이용됩니다.
세계에서 백혈병 및 기타 혈액 질환의 유병률이 증가하고 있는 것이 시장 성장을 가속하는 주요 요인 중 하나입니다. 또한 건강 관리 인프라 개선, 특히 신흥 국가의 혈액 은행과 외상 센터의 개척도 시장 성장을 가속하고 있습니다. 혈액 수집, 처리, 검사 및 보존과 관련된 활동에 대한 대중의 의식 증가는 면역 혈액 검사 장비 수요에 더 큰 영향을 미칩니다. 게다가 혁신적인 수혈 시스템과 전자동 장치의 개발 등 다양한 기술의 진보도 성장을 가속하는 요인이 되고 있습니다. 이러한 차세대 면역 혈액 검사 장비는 진단의 효능을 높이고 분석 시간과 인간 오류의 위험을 최소화하며 환자에게 긴급 지원을 제공하는 데 도움이 됩니다. 헌혈 캠프, 계발 프로그램 증가, 건강 관리 인프라 개선 등 기타 요인들도 시장을 더욱 견인할 것으로 예상됩니다.
이 보고서에서 다루는 주요 질문
- 세계의 면역혈액학 시장은 지금까지 어떻게 추이하고 향후 어떻게 추이해 나갈 것인가?
- 주요 지역 시장은?
- COVID-19는 세계의 면역혈액학 시장에 어떤 영향을 미쳤는가?
- 제품별 시장 분석은?
- 기술별 시장 분석은?
- 용도별 시장 분석은?
- 최종 사용자별 시장 분석은?
- 업계의 밸류체인의 다양한 단계란?
- 업계의 주요 촉진요인과 도전은 무엇인가?
- 세계의 면역혈액학 시장의 구조와 주요 기업은?
- 업계 경쟁도는?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사의 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 소개
제5장 세계의 면역혈액학 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 분석 : 제품별
제7장 시장 분석 : 기술별
- 바이오칩
- 젤 카드
- 마이크로플레이트
- 중합효소 연쇄반응
- 적혈구 자화 기술(EMT)
- 기타
제8장 시장 분석 : 용도별
제9장 시장 내역: 최종 사용자별
제10장 시장 내역: 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제11장 SWOT 분석
제12장 밸류체인 분석
제13장 Porter's Five Forces 분석
- 개요
- 구매자의 협상력
- 공급기업의 협상력
- 경쟁도
- 신규 참가업체의 위협
- 대체품의 위협
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업 프로파일
- Abbott
- Antisel
- BD(Becton Dickinson and Company)
- Beckman Coulter Inc.(Danaher Corporation)
- Bio-Rad Laboratories Inc.
- F. Hoffmann-La Roche Ltd.
- Grifols SA
- Merck KGaA
- MTC Invitro Diagnostics AG
- Ortho-Clinical Diagnostics Inc(The Carlyle Group)
- Siemens Healthcare GmbH
- Thermo Fisher Scientific Inc.
BJH
The global immunohematology market size reached US$ 1.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.8 Billion by 2032, exhibiting a growth rate (CAGR) of 4.2% during 2024-2032.
Immunohematology refers to a branch of medical sciences that studies blood and blood-forming tissues in relation to the immune system. It is used to study the presence of antigens in the blood and their reaction with antibodies that can either cause hemolysis or red blood cell (RBC) agglutination. Various immunohematology tests are conducted to ensure safe blood transfusion and prevent undesired immunity-, transplant-, and pregnancy-related reactions, and to diagnose blood related disorders and diseases such as HIV, Hepatitis, etc. They utilize various chemicals and devices, such as reagents, and automatic and semi-automatic analyzers that are based on the technology of microplates, biochips, gel cards, polymerase chain reaction and erythrocyte-magnetized technology (EMT).
The increasing prevalence of leukemia and other hematological disorders across the globe is one of the key factors driving the growth of the market. Furthermore, improvements in the healthcare infrastructure and the development of blood banks and trauma centers, especially in developing countries, is also providing a boost to the market growth. Increasing awareness among the masses regarding the activities associated with blood collection, processing, testing and storage has further created a positive impact on the demand for immunohematology devices. Additionally, various technological advancements, such as the development of innovative transfusion systems and fully-automated devices, are acting as other growth-inducing factors. These next-generation immunohematology devices aid in enhancing the efficacy of the diagnosis, minimizing analysis time and risk of human error, and providing emergency assistance to the patients. Other factors, including an increasing number of blood donation camps and awareness programs, along with improvements in the healthcare infrastructure, are projected to drive the market further.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global immunohematology market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, technology, application and end-user.
Breakup by Product:
Analyzing Systems
Reagents and Consumables
Breakup by Technology:
Biochips
Gel Cards
Microplates
Polymerase Chain Reaction
Erythrocyte-Magnetized Technology (EMT)
Others
Breakup by Application:
Blood-Related Diseases
HIV
Hepatitis
Blood Transfusion
Others
Breakup by End-User:
Hospitals
Blood Banks
Diagnostic Laboratories
Others
Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott, Antisel, BD (Becton Dickinson and Company), Beckman Coulter Inc. (Danaher Corporation), Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., Grifols S.A., Merck KGaA, MTC Invitro Diagnostics AG, Ortho-Clinical Diagnostics Inc (The Carlyle Group), Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., etc.
Key Questions Answered in This Report:
- How has the global immunohematology market performed so far and how will it perform in the coming years?
- What are the key regional markets?
- What has been the impact of COVID-19 on the global immunohematology market?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end-user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global immunohematology market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Immunohematology Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Analyzing Systems
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Reagents and Consumables
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Technology
- 7.1 Biochips
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Gel Cards
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Microplates
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Polymerase Chain Reaction
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Erythrocyte-Magnetized Technology (EMT)
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
- 7.6 Others
- 7.6.1 Market Trends
- 7.6.2 Market Forecast
8 Market Breakup by Application
- 8.1 Blood-Related Diseases
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 HIV
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Hepatitis
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Blood Transfusion
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End-User
- 9.1 Hospitals
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Blood Banks
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Diagnostic Laboratories
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.2 Asia Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.1.3 Financials
- 14.3.1.4 SWOT Analysis
- 14.3.2 Antisel
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.3 BD (Becton Dickinson and Company)
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Beckman Coulter Inc. (Danaher Corporation)
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 SWOT Analysis
- 14.3.5 Bio-Rad Laboratories Inc.
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.5.4 SWOT Analysis
- 14.3.6 F. Hoffmann-La Roche Ltd.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 SWOT Analysis
- 14.3.7 Grifols S.A.
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Merck KGaA
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.8.4 SWOT Analysis
- 14.3.9 MTC Invitro Diagnostics AG
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.10 Ortho-Clinical Diagnostics Inc (The Carlyle Group)
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 SWOT Analysis
- 14.3.11 Siemens Healthcare GmbH
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.11.4 SWOT Analysis
- 14.3.12 Thermo Fisher Scientific Inc.
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
